| Hans-Günter Meyer-Thompson | Legal
Global. Tilray® Signs Global Collaboration Agreement with Leading Pharmaceutical Company -- Tilray Inc. announced today that it entered into a global framework agreement (the “Framework Agreement”) to collaborate with Sandoz AG.
Global. Tilray® Signs Global Collaboration Agreement with Leading Pharmaceutical Company -- Tilray Inc. announced today that it entered into a global framework agreement (the “Framework Agreement”) to collaborate with Sandoz AG.
NANAIMO, B.C.– Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ: TLRY), a global pioneer in the production, research, and distribution of medical cannabis, announced today that it entered into a global framework agreement (the “Framework Agreement”) to collaborate with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars and a part of Novartis group, to increase availability of high quality medical cannabis products across the world. (Tilray Inc., Kanada, 18.12.2018)